Precursor Condition
Low Grade Squamous Intraepithelial Neoplasia
CI-CAN-00003069LSILExplore in graph →
Precursor6 active trials
- NCIt
- C8335
Loading cancer entity…
Loading cancer entity…
Precursor Condition
CI-CAN-00003069LSILExplore in graph →
Clinical trials
25 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05372016 | Evaluate the Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females | completed | Phase 3 | 1,200 | Shanghai Bovax Biotechnology Co., Ltd.INDUSTRY | 1 | Nov 24, 2023 | clinicaltrials |
| NCT04425291 | Evaluate the Immunogenicity and Safety of 4-valent and 9-valent HPV Recombinant Vaccine in Chinese Healthy Females | completed | Phase 3 | 1,680 | Shanghai Bovax Biotechnology Co., Ltd.INDUSTRY | 1 | Feb 25, 2022 |
| clinicaltrials |
| NCT01550783 | Home-Based or Clinic-Based Human Papillomavirus (HPV) Screening | completed | N/A | 1,335 | University of WashingtonOTHER | 1 | Jul 31, 2020 | clinicaltrials |
| NCT00201370 | A Multi-center Survey of HPV in Cervical Intraepithelial Neoplasia (CIN) With Longitudinal Follow-up of LSIL Cases | completed | — | 1,000 | National Health Research Institutes, TaiwanOTHER | 1 | Mar 25, 2016 | clinicaltrials |
| NCT00091130 | SGN-00101 Vaccine in Treating Human Papillomavirus in Patients Who Have Abnormal Cervical Cells | completed | Phase 2 | 139 | National Cancer Institute (NCI)NIH | 1 | Jun 3, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Nov 24, 2023source: clinicaltrials